A Phase I/II Study of Bosutinib in Pediatric Patients with Resistant/Intolerant or Newly Diagnosed Philadelphia Chromosome-Positive Chronic Myeloid Leukemia, Study ITCC (Innovative Therapies for Children with Cancer European Consortium) 054 and COG (Children's Oncology Group Consortium) AAML1921: Results from the Phase I Trial in Resistant/Intolerant Patients
Pennesi, Edoardo, Brivio, Erica, Willemse, Marieke E., Huitema, Alwin D.R., Chandra, Saurabh, Vijayakumar, Ashwini, Van Der Velden, Vincent H.J., Beverloo, H. Berna, Durairaj, Chandra, Viqueira, Andrea, Ingrosso, Antonella, Locatelli, Franco, Motwani, Jayashree, Bourquin, Jean-Pierre, Bautista Sirvent, Francisco J., Rizzari, Carmelo, Petit, Arnaud, Lancaster, Donna, Metzler, Markus, Bertrand, Yves, Murillo-Sanjuán, Laura, Bukowkinski, Andrew J., Krystal, Julie, Van Der Sluis, Inge M., Roth, Michael E., Van Tinteren, Harm, Hijiya, Nobuko, Zwaan, Christian M.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article